Prehospital epinephrine, vasopressin, and steroid for out-of-hospital cardiac arrest
Official title: A Randomized Clinical Trial of Patient Outcomes Following Out-of-Hospital Cardiac Arrest Receiving Epinephrine Versus In-together Vasopressin, Epinephrine, and Steroid. (OHCA REVIVES Trial)
Run by National Taiwan University Hospital · NCT06203847 · Data updated 2026-11-12
This trial tests whether giving epinephrine together with vasopressin and a steroid in the ambulance helps adults with non‑traumatic out‑of‑hospital cardiac arrest in Taipei and New Taipei City achieve sustained return of spontaneous circulation.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 1344 (estimated) |
| Sponsor | National Taiwan University Hospital Academic / other |
| Locations | 1 site (Taipei) |
| Status | Recruiting |
| Started | July 16, 2024 |
| Main results expected | July 31, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | November 19, 2025 |
| Trial ID | NCT06203847 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 or older who suffer non‑traumatic out‑of‑hospital cardiac arrest within the Taipei City or New Taipei City EMS systems and are resuscitated by trial‑trained paramedics with vascular access established are the intended participants.
✕Probably not a fit
Patients with traumatic cardiac arrest, obvious signs of death, DNR orders, known or suspected pregnancy, ROSC before medication, no vascular access, or who received epinephrine before trial paramedics arrive are unlikely to be eligible or receive benefit from the intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a randomized prehospital clinical trial comparing standard epinephrine alone to a combination of epinephrine, vasopressin, and methylprednisolone administered by trained paramedics. The combination arm uses standard epinephrine doses with 20 U vasopressin after each epinephrine dose (up to 80 U) and a single 40 mg dose of methylprednisolone after the first epinephrine. The primary outcome is sustained return of spontaneous circulation (ROSC) and secondary outcomes include longer-term survival. The trial plans to enroll about 1,344 adult non‑traumatic OHCA patients treated by EMS in Taipei City and New Taipei City.
Why it matters
Potential benefit: If successful, the combination treatment could increase rates of sustained ROSC and improve longer-term survival after out‑of‑hospital cardiac arrest.
How similar studies have gone: Previous randomized work combining vasopressin, steroids, and epinephrine showed promising results in some in‑hospital cardiac arrest populations, but evidence for prehospital OHCA is limited and results have been mixed.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult patients (aged \>= 18 ) * Out-of-hospital cardiac arrest in the studied regions * Treated by paramedics authorized and capable of giving prehospital medication Exclusion Criteria: * OHCA with traumatic etiology * Obvious signs of death like decapitation, rigor mortis, livor mortis, decomposition, etc. * DNR (Do Not Resuscitation) or termination of resuscitation requested by the family * Patients with known or suspected pregnancy * No vascular access was established before hospital arrival * ROSC before the administrated medication * No patient contact (cancelled ambulance call or the patient was transported to the hospital before the arrival of trial-trained paramedics) * Received epinephrine prior to the arrival of trial-trained paramedics
Where it's running
-
National Taiwan University Hospital
Taipei, Taiwan Recruiting
Study contacts
- Principal investigator: WEN CHU CHIANG, Phd — National Taiwan University Hospital
- Study coordinator: WEN CHU CHIANG, PhD
- Email: drchiang.tw@gmail.com
- Phone: +886 926131851
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Initial double sequential defibrillation for out-of-hospital ventricular fibrillation
This trial will test whether using two defibrillators to give double sequential shocks first improves survival for adults with out-of-hospital cardiac arrest and a shockable rhythm.
-
Innovative technologies to improve cardiac arrest resuscitation effectiveness
This study is testing new technology, like smartphone apps and wearable devices, to see if it can help improve CPR and defibrillation for people who have a cardiac arrest outside of the hospital.
-
Improving survival rates for out-of-hospital cardiac arrest using advanced CPR techniques
This study is testing new CPR techniques and devices to see if they can help adults who have a cardiac arrest outside of the hospital survive and maintain normal brain function.
-
Comparing two CPR methods for out-of-hospital cardiac arrest
This study is testing whether Chest Compression Only CPR is just as effective as Standard CPR for helping people who have a cardiac arrest outside of the hospital.
-
Minimal Sedation After Out-of-Hospital Cardiac Arrest
This study tests whether stopping continuous sedation right after return of circulation is as safe as keeping patients sedated in the early hours after OHCA.
-
Heartsight helps caregivers of kids after cardiac arrest manage uncertainty and fear
This pilot trial tests if the Heartsight information program is acceptable and helpful for caregivers of children who recently had a cardiac arrest.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.